Current Location: Home >Markets >Immix... recnac latceroloc ni 011-XMI r

Immix... recnac latceroloc ni 011-XMI r

2025-06-09 16:19:19 [Podcasts & Videos] Source:
Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

(Editor in charge: Podcasts & Videos)

    Recommended Articles
    Popular Reads